| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00792948 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P582 | end time | 2016-06-01 | |
| P4135 | maximum age | 60 | |
| P1050 | medical condition | leukemia | Q29496 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 97 | |
| P4844 | research intervention | sirolimus | Q32089 |
| folic acid | Q127060 | ||
| doxorubicin | Q18936 | ||
| leucovorin calcium | Q27077063 | ||
| prednisolone acetate | Q27108063 | ||
| etoposide phosphate | Q27260984 | ||
| methylprednisolone hemisuccinate | Q27262132 | ||
| prednisolone 21-phosphate | Q27266327 | ||
| Caelyx | Q29004943 | ||
| cortisone acetate | Q39045244 | ||
| prednisolone | Q11426176 | ||
| cytarabine | Q180983 | ||
| (RS)-cyclophosphamide | Q408524 | ||
| calcium oxalate | Q412399 | ||
| methylprednisolone | Q417222 | ||
| dasatinib | Q419940 | ||
| podofilox | Q421193 | ||
| prednisone | Q424972 | ||
| sargramostim | Q3950557 | ||
| P6153 | research site | West Virginia University | Q115376 |
| Vanderbilt University | Q29052 | ||
| University of Chicago | Q131252 | ||
| University of Rochester | Q149990 | ||
| Medical University of South Carolina | Q6806451 | ||
| Memorial Medical Center | Q6815474 | ||
| Munson Medical Center | Q6936903 | ||
| Roswell Park Comprehensive Cancer Center | Q7370121 | ||
| University of Oklahoma Health Sciences Center | Q7896014 | ||
| Washington University School of Medicine | Q7972509 | ||
| Wesley Medical Center | Q7983961 | ||
| University of North Carolina at Chapel Hill | Q192334 | ||
| Johns Hopkins University | Q193727 | ||
| University of Michigan | Q230492 | ||
| Northwestern University | Q309350 | ||
| Saint Louis University | Q734774 | ||
| Case Western Reserve University | Q1047060 | ||
| Yeshiva University | Q1048851 | ||
| Mayo Clinic | Q1130172 | ||
| Tulane University | Q1193547 | ||
| Fred Hutchinson Cancer Research Center | Q1452369 | ||
| Cleveland Clinic | Q4117596 | ||
| Intermountain Medical Center | Q6047575 | ||
| Loyola University Medical Center | Q6694611 | ||
| Medical College of Wisconsin | Q6806307 | ||
| P580 | start time | 2009-09-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) With or Without Allogeneic Stem Cell Transplant in Patients With Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study) |